Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

FASEB Journal

Volumn 19, Issue 13, 2005, Pages 1842-1844

  Poole, Kenneth E S ^a   Van Bezooijen, Rutger L ^b   Loveridge, Nigel ^a   Hamersma, Herman ^c   Papapoulos, Socrates E ^b   Löwik, Clemens W ^b   Reeve, Jonathan ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GLYCOPROTEIN; SCLEROSTIN; UNCLASSIFIED DRUG;

ARTICLE; BONE MINERALIZATION; CELL MATURATION; CELL PROLIFERATION; GENE; HUMAN; HUMAN TISSUE; ILIAC BONE; OSSIFICATION; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; SOST GENE;

AGED; ALKALINE PHOSPHATASE; ANTIBODIES, MONOCLONAL; BIOPSY; BONE AND BONES; BONE DEVELOPMENT; BONE DISEASES, DEVELOPMENTAL; BONE MORPHOGENETIC PROTEINS; BONE REMODELING; BONE RESORPTION; CELL DIFFERENTIATION; COLORING AGENTS; FEMALE; GENETIC MARKERS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MODELS, BIOLOGICAL; OSTEOBLASTS; OSTEOCYTES; OSTEOGENESIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TOLONIUM CHLORIDE;

EID: 27744461726     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-4221fje     Document Type: Article

References (0)